6-9 September 2018 | Kaohsiung, Taiwan

20th Asia Pacific League of Associations for Rheumatology Congress

6-9 September 2018 | Kaohsiung, Taiwan

The different patient journeys for chronic inflammatory disease

Professor Luo Shue-Fen from Taipei Chang Gung Memorial Hospital,Taiwan, will introduce the symposium by sharing the experiences and challenges faced by patients with chronic inflammatory diseases in Asia-Pacific.
Early diagnosis and treat-to-target are key principles in the management of rheumatoid arthritis (RA) in recent years, having proven successful in achieving better disease control. Substantial improvements in disease control have been further achieved with the introduction of biologics, including anti-TNF agents. What are the key considerations for the choice of a first biologic in RA? Professor Yoshiya Tanaka from the University of Occupational and Environmental Health, Japan, will review key data to demonstrate the role of biologics in improving clinical outcomes for newly diagnosed patients, and will consider the possibility of disease control after biologic discontinuation. This evidence from clinical trials and real-world experience will guide treatment of RA patients in early course of their disease.
Most women are of childbearing age at the onset of chronic rheumatic diseases, and have significant fears, anxiety, and misconceptions before, during and after pregnancy. Accordingly, family planning is often delayed, and many are not actively planning their pregnancy during conception. The majority of women stop treatment during pregnancy for fear of harming their child. Despite the perception that disease outcomes can improve during pregnancy, ~50% of women with chronic rheumatic diseases still need therapeutic intervention to achieve adequate disease control and prevent consequences of active disease on their foetus. Additionally, postpartum flares occur in 40–90% of patients, often leading to a trade-off between treatment and breastfeeding. Adequate disease control before, during and after pregnancy is crucial for best maternal and foetal health. Dr Rebecca Fischer-Betz from Heinrich-Heine-University Hospital, Düsseldorf, Germany, will review recent guidelines and evidence that can aid decision-making and support earlier conversations on family planning for women with chronic rheumatic diseases.
Chair
Prof. Luo, Shue-Fen, Taipei Chang Gung Memorial Hospital, Taiwan
Speakers
Prof. Yoshiya Tanaka, University of Occupational and Environmental Health, Japan
Dr Rebecca Fischer-Betz, MD, PhD, Heinrich-Heine-University, Düsseldorf, Germany
Agenda
Considerations for your first biologic – Prof. Yoshiya Tanaka
Starting the conversation earlier for women of child bearing age – Dr Rebecca Fischer-Betz, MD, PhD